MetaCap

Sensus Healthcare Inc. (SRTS)

NASDAQ: SRTSHealth CareMedical/Dental InstrumentsUSD

2.26-0.10 (-4.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SRTS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$37.20M
EPS (TTM)
-$0.97
52-week range
2.14 – 5.49
Day range
2.22 – 2.41
Volume / Avg
122.02K / 208.74K
Beta
—

52-week range

$2.14$5.49

SRTS stock today

Sensus Healthcare (SRTS) closed at $2.26 on Nov 20, down 4.24% (-$0.10), versus the S&P 500's 3.70% decline. At this level, SRTS sits near the bottom of its 52-week range of $2.14 to $5.49: 58.8% below the high, set on Jan 13, 2026 and 5.6% above the low. SRTS is down 43.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 43.8%.

Sensus Healthcare has posted a net loss over the last twelve months (EPS of -$0.97), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Sensus Healthcare

Company profile

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices.

Industry
Medical/Dental Instruments
CEO
Mr. Joseph C. Sardano
Headquarters
Boca Raton, FL
Employees
60
IPO year
2016

Financial highlights

Full financials

In fiscal 2025, Sensus Healthcare generated $27.5 million in revenue, down 34.3% from fiscal 2024, its first annual decline since 2023. Sensus Healthcare reported a net loss of $7.7 million, compared with net income of $6.6 million a year earlier. Gross margin was 43.2% (down from 58.4%) and operating margin -37.5%.

Sensus Healthcare annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$27.48M$41.81M$24.41M$44.53M$27.04M
Growth-34.26%+71.31%-45.20%+64.68%+182.36%
Net income$-7.72M$6.65M$485.00K$24.24M$4.12M
EPS (diluted)$-0.47$0.41$0.03$1.46$0.25

Analyst forecast

Forecast

Consensus (4 analysts)

none

Avg. price target

$5.38+138.05%

  • Strong buy 1
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $4.00High $6.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.06 vs —

SRTS news

All SRTS news

Sensus Healthcare peers

Health Care sector
SRTS peer companies
CompanyPrice% ChgMarket capCompare
MDAISpectral AI Inc. Class A1.04-20.61%$33.47Mvs SRTS
TELATELA Bio Inc.0.6885-5.27%$31.11Mvs SRTS
DXRDaxor Corporation7.45-7.33%$43.49Mvs SRTS
XTNTXtant Medical Holdings Inc.0.21-2.82%$29.49Mvs SRTS
NSPRInspireMD Inc.0.54-12.97%$29.23Mvs SRTS
MBOTMicrobot Medical Inc.0.68-8.52%$45.67Mvs SRTS
NEPHNephros Inc.2.61-8.10%$28.37Mvs SRTS
PLRZPolyrizon Ltd.9.31-8.42%$22.61Mvs SRTS

Indexes, lists and sector

Sensus Healthcare stock FAQ

What is Sensus Healthcare's stock price today?

SRTS last traded at $2.26 as of Nov 20, 4:00 PM EST, down 4.24% on the day. Prices are delayed at least 15 minutes.

Who is Sensus Healthcare's CEO?

Mr. Joseph C. Sardano is the chief executive officer of Sensus Healthcare Inc., which has about 60 employees.

What is the SRTS 52-week high?

The 52-week high for SRTS is $5.49 and the 52-week low is $2.14. The stock is currently 58.8% below its high.

Compare SRTS